Indrayani Biotech Quarterly Results for Trading Insights
In Sept 2025, Indrayani Biotech (INDRANIB) reported revenue ₹38 Cr and net profit ₹1 Cr — revenue +22.6% YoY. Also explore INDRANIB stock price history to track price trends across different timeframes.
INDRANIB Quarterly Results — Revenue, Profit & EPS Highlights
Indrayani Biotech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Browse Indrayani Biotech annual reports for revenue, profit, balance sheet and cash flow data.
- Revenue of ₹38 Cr in Sept 2025 (-28.3% vs Mar 2025, +22.6% vs Sept 2024)
- Net Profit of ₹1 Cr in Sept 2025 (+111.1% vs Mar 2025, +0.0% vs Sept 2024)
- EBITDA of ₹4 Cr in Sept 2025
- Operating Margin of 7.0% in Sept 2025 (+13.0pp vs Mar 2025)
- Earnings Per Share of ₹0.09 in Sept 2025 (+106.3% vs Mar 2025)
Indrayani Biotech Quarterly Results — Revenue, EBITDA, Net Profit & EPS
INDRANIB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 38 | 53 | 30 | 36 | 31 | -28.3% | 22.6% |
| Net Profit (₹ Cr) | 1 | -9 | 0 | 0 | 1 | - | - |
| EBITDA (₹ Cr) | 4 | 0 | 3 | 4 | 5 | - | - |
| EPS (₹) | 0.09 | -1.42 | 0.03 | 0.01 | 0.13 | - | - |
| Operating Margin (%) | 7.0% | -6.0% | 7.0% | 8.0% | 17.0% | - | - |
INDRANIB Share Price Trend — 1-Year Movement Across Quarterly Results
Indrayani Biotech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Indrayani Biotech share price chart.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
INDRANIB vs FMCG Peers — Quarterly Revenue, Profit & Market Cap
Indrayani Biotech latest quarter revenue and net profit vs FMCG competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Hindustan Unilever
Mar 2026 |
₹503,705.37 Cr | 2139.7 | 16,718 | 2,994 | +3.8% | +9.3% | 17.9% | 168.1 |
|
ITC
Mar 2026 |
₹351,702.17 Cr | 282.7 | 18,354 | 5,470 | -8.4% | -45.9% | 29.8% | 65.7 |
|
Marico
Mar 2026 |
₹111,050.05 Cr | 855.3 | 3,393 | 408 | -3.9% | +22.2% | 12.0% | 281.3 |
|
Patanjali Foods
Mar 2026 |
₹36,745.43 Cr | 339.2 | 11,212 | 524 | +14.1% | +15.1% | 4.7% | 70.4 |
|
AWL Agri Business
Mar 2026 |
₹24,599.02 Cr | 189.4 | 21,623 | 293 | +23.4% | +18.2% | 1.4% | 83.8 |
All amounts in ₹ Crores